Citable company snapshot
Merck & Co.'s latest SEC-sourced 2026-06-30 period shows $16.61B in revenue and $-1.33B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $16.61B | $16.29B | +2.0% |
| Net Income | Jun 30, 2026 | $-1.33B | $-4.24B | +68.5% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $5.37B | $3.92B | +37.1% |
| Free Cash Flow (computed) | Jun 30, 2026 | $4.48B | $2.93B | +53.0% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 7, 2026; accession 0000310158-26-000212.
MRK company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.